What is it about?
This publication describes the isolation and characterization of a bacteriophage virus targeting the bacterial pathogen Shigella flexneri.
Featured Image
Why is it important?
This work not only highlights the identification of a pathogen-specific bacteriophage, but also demonstrates the use of a novel, human-specific model of the gastrointestinal epithelium that can be used as a therapeutic candidate screening platform.
Read the Original
This page is a summary of: Bacteriophage Therapy Testing against Shigella flexneri in a Novel Human Intestinal Organoid-Derived Infection Model, Journal of Pediatric Gastroenterology and Nutrition, November 2018, Wolters Kluwer Health,
DOI: 10.1097/mpg.0000000000002203.
You can read the full text:
Contributors
The following have contributed to this page